Alzheimer's disease (AD) is a neurodegenerative disorder with neuronal and synaptic
losses due to the accumulation of toxic amyloid β (Αβ) peptide oligomers, plaques, and …

The scientists are dedicated to studying the detection of Alzheimer's disease onset to find a
cure, or at the very least, medication that can slow the progression of the disease. This …

Neuroimaging biomarkers have shown high potential to map the disease processes in the
application to neurodegenerative diseases (NDD), eg, diffusion tensor imaging (DTI). For …

Background The diagnosis of sepsis associated encephalopathy (SAE) remains challenging
in clinical settings because of a lack of specific biomarkers. Functional magnetic resonance …

Alzheimer's disease (AD) is a degenerative disease of the central nervous system
characterized by memory and cognitive dysfunction, as well as abnormal changes in …

The default mode network (DMN) is a prominent neural network in the human brain that
exhibits a substantial association with Alzheimer's disease (AD). Functional connectivity …

The most common type of dementia in neurodegenerative diseases is Alzheimer's disease
(AD), a progressive neurological illness that causes memory loss. Neurophysiological tests …

The scientists are dedicated to studying the detection of Alzheimer's disease onset to find a
cure, or at the very least, medication that can slow the progression of the disease. This …

The default mode network (DMN) is a large neural network that has a significant correlation
with Alzheimer's disease (AD). Grey matter volume (GMV) and functional connectivity (FC) …

Dementia is a spectrum of diseases characterised by a progressive and irreversible decline
in cognitive function. Appropriate tools and references are essential for evaluating …